Today: 11 June 2026
Northern Star share price rebounds after bruising selloff — what to watch before ASX reopens
24 January 2026
1 min read

Northern Star share price rebounds after bruising selloff — what to watch before ASX reopens

Sydney, Jan 24, 2026, 16:56 (AEDT) — Market closed.

Northern Star Resources (NST.AX) shares rebounded on Friday, climbing 5.4% to A$27.60. The bounce followed a steep drop the previous day, after the gold miner warned of rising costs and increased growth investments.

The stock is entering a long weekend in Australia, where the market will be closed Monday for the Australia Day public holiday. Trading resumes with the next cash equity session on Tuesday.

That gap is significant. Investors get more time to determine if Northern Star’s recent quarterly miss stems from isolated plant and mine issues or signals ongoing challenges with execution and rising costs.

Northern Star reported selling 348,061 ounces of gold in the December quarter at an all-in sustaining cost (AISC) of A$2,937 per ounce. The company said “one-off operational events” across its sites hit sales and forced a reset of full-year targets. It maintained its revised FY26 guidance of 1.6–1.7 million ounces sold and an AISC range of A$2,600–2,800 per ounce. Meanwhile, capex for the KCGM mill expansion increased to A$640–660 million from the previous A$530–550 million. Underlying free cash flow came in negative at A$328 million. Managing Director Stuart Tonkin described the disruptions as causing a “softer December quarter.” nsrltd.com

AISC measures the total expense of producing each ounce, combining running costs with sustaining capital. If sales drop, those fixed costs get allocated across fewer ounces, causing the per-ounce cost to spike quickly.

Bears face a tough moment. Gold surged to a record $4,988 an ounce Friday, while silver topped $100, pushing bullion-linked stocks into focus. Yet, some analysts caution these momentum-fueled rallies can snap back sharply.

Australia’s ASX 200 managed a modest 0.13% rise on Friday, finishing at 8,860. Spot gold held steady above $4,900 an ounce late in the session, according to market reports.

Some fund managers remain fixated on credibility. Ben Lyons, Jarden’s director of equity research, told The Australian, “It is not often you see a $35bn company get a please explain from the ASX about their continuous disclosure obligations.” The Australian

The downside remains clear. Should throughput and grades fail to bounce back at Kalgoorlie, Yandal, and Pogo — or if cash continues to drain into the mill expansion and other growth projects — the company could face yet another round of guidance cuts despite strong bullion prices.

The upcoming session will depend on whether traders continue to buy gold leverage following the recent break or start taking profits after a turbulent week for metals and miners. Northern Star’s figures highlight just how fast increased royalties and hefty capex can erode the gains from a rising gold price.

The next major event is the company’s FY26 half-year results, set for Feb. 12. Investors will be watching closely for signs that production is stabilizing and that the rising cost and capex overruns are finally being contained.

Stock Market Today

  • AMD Stock Price Forecast: Analyst Lowers Target Amid AI Market Caution
    June 11, 2026, 11:00 AM EDT. Shares of Advanced Micro Devices (AMD) have surged 111% year-to-date, driven by investor optimism over its expanding role in the artificial intelligence (AI) sector. Despite the strong performance, a prominent AI-focused analyst has trimmed the price target for AMD, signaling caution about the chipmaker's near-term prospects. The analyst cited concerns over competitive pressures and potential market saturation. AMD's growth is largely tied to its ability to capture demand in AI computing, a fast-evolving field requiring specialized semiconductor technology. Investors are weighing the company's robust sales against risks from supply chain constraints and intensifying industry competition.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 24.01.2026

Fortinet stock jumps on TD Cowen upgrade — what FTNT investors watch before earnings
Next Story

Fortinet stock jumps on TD Cowen upgrade — what FTNT investors watch before earnings

Go toTop